Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Blood Counts as Biomarkers? Haematologic Clues to Natalizumab Response in Multiple Sclerosis
Genetics
Blood Counts as Biomarkers? Haematologic Clues to Natalizumab Response in Multiple Sclerosis

13, Jun 2025

2
Blood Counts as Biomarkers? Haematologic Clues to Natalizumab Response in Multiple Sclerosis
Genetics
Could Paraoxonase1 (PON1) Be the Unsung Hero in Multiple Sclerosis Treatment Monitoring?

12, Jun 2025

3
Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS
Genetics
Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS

11, Jun 2025

4
Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments
Genetics
Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments

10, Jun 2025

5
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis
Genetics
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis

09, Jun 2025

Categories:
Genetics
Genetic Discovery in Rare Diseases: Uncovering the Underlying Genetic Etiologies of 269 Disorders
Genetics
Genetic Discovery in Rare Diseases: Uncovering the Underlying Genetic Etiologies of 269 Disorders

14, Nov 2024

Natural Killer Cells in Multiple Sclerosis: A New Frontier in Immune Research
Genetics
Natural Killer Cells in Multiple Sclerosis: A New Frontier in Immune Research

15, Nov 2024

Charting the Genetic Background of Multiple Sclerosis: Landmark GWAS Insights
Genetics
Charting the Genetic Background of Multiple Sclerosis: Landmark GWAS Insights

16, Nov 2024

Bruton Tyrosine Kinase Inhibitors: A New Frontier in Multiple Sclerosis Treatment
Genetics
Bruton Tyrosine Kinase Inhibitors: A New Frontier in Multiple Sclerosis Treatment

18, Nov 2024